期刊文献+

FK506对GAP_(-43)和Tau蛋白活性影响的实验研究 被引量:2

Experimental study of the effect of FK506 on GAP_(-43) and Tau protein activity
原文传递
导出
摘要 目的观察FK506缓释膜片对大鼠神经损伤后生长相关蛋白(Growthassociatedprotein43,GAP43)和Tau蛋白活性的影响。方法将FK506缓释膜片(释放速度为1mg·d,共21d)放置于损伤坐骨神经周围为实验组,损伤坐骨神经周围不放置药物者为对照组。于术后3d,术后1、2、3、4、6和8周共7个时间组,分别取神经缝合口近端和远端的神经段、腰段脊神经节及脊髓腰膨大,用SABC法检测GAP43及Tau蛋白的阳性标记量。结果实验组于术后1~4周已出现GAP43及Tau蛋白表达增强,与对照组相比差异有统计学意义(P<0.01)。结论FK506能增加GAP43及Tau蛋白表达,对周围神经损伤后的神经再生有一定的促进作用。 Objective To observe the influence of FK506 on GAP -43 and Tau protein activity after nerve injuries in Wistar rats. Methods Sciatic nerve injury model was established in Wister rats. In the experimental group, FK506 was delivered via a slow-release film that was wrapped around the repair site. In the control group, only nerve repair was done. At 3 days,1, 2, 3, 4, 6 and 8 weeks after the operation,the proximal and distal end of the neurorrhaphy, dorsal root ganglia, and spinal cord were harvested. Expression of GAP-43 and Tau protein were detected by determine the labelled amount using SABC method. Results In the experimental group, the expression of GAP -43 and Tau protein was increased 1 to 4 weeks postoperatively. The difference was statistically significant. Conclusion FK506 can increase the expression of GAP -43 and Tau protein in the peripheral nerve. It thus might promote nerve regeneration following nerve injuries.
出处 《中华手外科杂志》 CSCD 北大核心 2005年第3期183-185,共3页 Chinese Journal of Hand Surgery
基金 广东省科技厅科技攻关基金资助项目(2003C33812) 深圳市科技局科研基金资助项目(200204179)
  • 相关文献

参考文献9

二级参考文献56

  • 1Navarro X, Udina E, Ceballos D, et al. Muscle Nerve, 2001, 24(7) :905-915.
  • 2Schwartz M,Sela BA,Eshhar N. J Neurochem,1982, 38(5) : 1192-1195.
  • 3de Medinaceli L, Church AC, Wang YN. Exp Neurol, 1985,88(2) :372-384.
  • 4Ansselln AD,Pollard JD. J Neurol Sci, 1990,96(1) :75-88.
  • 5Becker DB, Jensen JN, Myckatyn TM, et al. J ReconstrMicrosurg, 2000, 16 (8):613 - 620.
  • 6Bavetta S, Hamlyn PJ, Burnstock G, et al. Exp Neurol, 1999 , 158(2):382-393.
  • 7Gold BG. Expert Opin Investig Drugs,2002,9(10):2331-2341.
  • 8Wang MS, Zeleny-Pooley M,Gold BG. J Pharmacol Exp Ther,1997,282(2) :1084-1093.
  • 9Steiner JP, Hamilton GS, Ross DT, et al. Proc Natl Acad SciUSA, 1997,94(5) :2019-2024.
  • 10Steiner JP,Connolly MA, Valentine HL, et al. Nat Med, 1997, 3(4) :421-428.

共引文献112

同被引文献25

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部